SCHEMBL28485486

SCHEMBL28485486

CN1CCN(S(=O)(=O)c2[c]c([N+](=O)[O-])cc([N+](=O)[O-])c2)CC1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
VCAM1 P19320 1/20 0.47
L3MBTL1 Q9Y468 4/20 0.42
LMNA P02545 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ATM Q13315 1/20 0.39
SIRT6 Q8N6T7 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28473212 0.95 ALDH1A1 (0.46) HTTALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL28486029 0.92 L3MBTL1 (0.43) HTTALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL28474493 0.86 HTT (0.47) HTTALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL29202924 0.86 MAPT (0.56) HTTALDH1A1KMT2AMAPT
SCHEMBL28480715 0.82 KMT2A (0.47) HTTALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL28472349 0.82 HTT (0.44) HTTALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL28482466 0.82 SMN1; SMN2 (0.44) HTTALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL29202914 0.81 ALDH1A1 (0.40) HTTALDH1A1SMN1; SMN2L3MBTL1LMNA
SCHEMBL28901016 0.79 L3MBTL1 (0.46) HTTALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL28485413 0.78 ALDH1A1 (0.53) HTTALDH1A1CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111918864-B Prodrug compounds activated by AKR1C3 and their use for the treatment of hyperproliferative disorders 阿基利斯医疗有限公司 2024-03-05 CN disclosed
CN-111918864-A Prodrug compounds activated by AKR1C3 and their use to treat hyperproliferative disorders 阿基利斯医疗有限公司 2020-11-10 CN disclosed